The effects of a muscle resistance program on the functional capacity, knee extensor muscle strength and plasma levels of IL-6 and TNF-α in pre-frail elderly women: A randomized crossover clinical trial - a study protocol

Trials

Volumn 11, Issue , 2010, Pages

  Lustosa, Lygia P ^a   Coelho, Fernanda M ^b   Silva, Juscelio P ^b   Pereira, Daniele S ^b   Parentoni, Adriana N ^c   Dias, João M D ^b   Dias, Rosangela C ^b   Pereira, Leani S M ^b  

^a CENTRO UNIVERSITÁRIO NEWTON PAIVA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSIDADE FEDERAL DOS VALES DO JEQUITINHONHA E MUCURI   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DYNAMOMETER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; EXTENSOR MUSCLE; FEMALE; FRAIL ELDERLY; FUNCTIONAL STATUS; HUMAN; HUMAN EXPERIMENT; KNEE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE TRAINING; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; BLOOD; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; FITNESS; FOLLOW UP; KINESIOTHERAPY; LEG; METHODOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SKELETAL MUSCLE; WEIGHT BEARING;

AGED; AGED, 80 AND OVER; CROSS-OVER STUDIES; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; FRAIL ELDERLY; HUMANS; INTERLEUKIN-6; KNEE JOINT; LEG; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHYSICAL FITNESS; SAMPLE SIZE; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT-BEARING;

EID: 77955504835     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-82     Document Type: Article

References (40)

1. Carvalho JAM, Rodriíguez-Wong LL. A transição da estrutura etária da população brasileira na primeira metade do século XXI. Cad Saúde Pública 2008, 24(3):597-605.
2. Veras R. Envelhecimento populacional contemporâneo: demandas, desafios e inovações. Rev Saúde Pública 2009, 43(3):548-54.
3. Walston J, Hadley E, Ferrucci L, Guralnik J, Newman A, Studensk A, William B, Ershler M, Harris T, Fried LP. Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006, 54:991-1001. 10.1111/j.1532-5415.2006.00745.x, 16776798.
4. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. Journal of Gerontology: Med Sci 2004, 59(3):255-63.
5. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA;. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:146-56.
6. Ershler WB, Keller ET. Aged-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000, 51:245-70. 10.1146/annurev.med.51.1.245, 10774463.
7. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003, 114:180-7. 10.1016/S0002-9343(02)01484-5, 12637131.
8. Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, Leveille SG, Fried LP, Md JM. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geritr Soc 2002, 50:1947-54.
9. Doherty TJ. Physiology of aging. Invited review: aging and sarcopenia. J Appl Physiol 2003, 95:1717-27.
10. Roubenoff R. Catabolism of aging: is it an inflammatory process?. Curr Opin Nutr Metab Care 2003, 6:295-9.
11. Schaap L, Pluijm MFS, Deeg DJH, Visser M. Inflammatory markers and loss muscle mass (Sarcopenia) and strength. Am J of Med 2006, 119:526-7.
12. Pedersen BK. IL-6 signalling in exercise and desease. Biochemical Society Transactions 2007, 1295-7.
13. Krabbe KS, Pedersen MP, Bruunsgaard H. Inflammatory mediators in the elderly. Experimental Gerontol 2004, 39:687-99.
14. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. L Leukoc Biol 2005, 78:819-35.
15. Abbas AK, Lichtman AH, Pillai S. Imunologia Celular e Molecular. 2008, Rio de Janeiro: Elsevier, 6a.
16. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor a in frail elderly humans. Faseb J 2001, 15:475-82. 10.1096/fj.00-0274com, 11156963.
17. Ferrucci L, Guralnik JM, Studensk S, Fried LP, Cutler GB, Walston JD. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 2004, 52:625-34. 10.1111/j.1532-5415.2004.52174.x, 15066083.
18. Matiello-Sverzut AC. Histopatologia do músculo esquelético no processo de envelhecimento e fundamentação para a prática terapêutica de exercícios físicos e prevenção da sarcopenia. Rev Fisioter Univ SP 2003, 10:24-33.
19. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98:1154-62. 10.1152/japplphysiol.00164.2004, 15772055.
20. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur studies of successful aging. J Am Geriatr Soc 2003, 51:1125-30. 10.1046/j.1532-5415.2003.51380.x, 12890077.
21. Maciel ACC, Guerra RO. Prevalência e fatores associados ao déficit de equilíbrio em idosos. Rev Bras Ciências e Mov 2005, 13(1):37-44.
22. Drukker M, DeBie RA, VanRossum E. The effects of exercise training in institutionalized elderly people: a systematic review. Phys Ther Reviews 2001, 6(4):273-85.
23. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. Faseb J 2002, 16:1335-47. 10.1096/fj.01-0876rev, 12205025.
24. Drela N, Kozdron E, Szczypiorski P. Moderate exercise may attenuate some aspects of immunosenescence. BMC Geriatrics 2004, 4:8-10. 10.1186/1471-2318-4-8, 524506, 15456521.
25. Eyigor S, Karapolat H, Durmaz B. Effects of a group-based exercise programo n the physical performance, muscle strength and quality of life in older women. Arch Gerontol Geriat 2007, 45(3):259-71.
26. Tracy BL, Ivey FM, Hurbut D, Martel GF, Lemmer JT, Siegel EL, Metter EJ, Fozard JL, Fleg JL, Hurley BF. Muscle quality II. Effects of strength training in 65 to 75 yr-old men and women. J Appl Physiol 1999, 86(1):195-201.
27. Kryger AI, Andersen JL. Resistence training in the oldest old: consequences for muscle strength, fiber types, fiber size and MHC isoforms. Scand J Med Sci Sports 2007, 17:422-30. 10.1111/j.1600-0838.2006.00575.x, 17490465.
28. Plomgaard P, Keller P, Keller C, Pedersen BK. TNF-α, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue. J Appl Physiol 2005, 95:2019-23.
29. Paixão CM, Reichenheim ME. Uma revisão sobre instrumentos de avaliação do estado funcional do idoso. Cad Saúde Pub 2005, 21(1):7-19.
30. Huang MH, Lin YS, Yang RC, Lee CL. A comparison of various therapeutic exercises on the functional status of patients with knee osteoarthritis. Semin Arthritis Rheum 2003, 32(6):398-406. 10.1053/sarh.2003.50021, 12833248.
31. Bertolucci P, Brucki S, Campacci S. O mini-exame do estado mental em uma população geral. Arq Neuropsiquiatr 1994, 52(1):1-7.
32. Alaaeddine N, DiBattista JA, Pelletier JP, Cloutier JM, Kiansa K, Dupuis M, Martel-Pelletier. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. J Rheumatol 1997, 24(10):1985-94.
33. Podsiadlo D, Richardson S. The Timed Up & Go: a test of basic functional mobility for frail elderly persons. Jags 1991, 39:142-8.
34. Shinkai S, Watanabe S, Kumagai S, Fujiwara Y, Amano H, Yoshida H, Ishizaki T, Yakawa H, Suzuki T, Shibata H. Walking speed as a good predictor for the onset of functional dependence in a Japanese rural community population. Age and Ageing. 2000, 29:441-6.
35. Baltzopoulos V, Brodie DA. Isokinetic dynamometry, applications and limitations. Sports Med 1989, 8(2):101-16. 10.2165/00007256-198908020-00003, 2675256.
36. Oliveira DMG, Narciso FMS, Santos MLA, Pereira DS, Coelho FM, Dias JMD, Pereira LSM. Muscle strength but not functional capacity is associated with plasma interleukin-6 levels of community-dwelling elderly women. Brazil J Med and Biol Res 2008, 41:1148-53.
37. Haack M, Pollmacher T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in health volunteers. Brain, Behavior, and Immunity 2004, 18:361-67. 10.1016/j.bbi.2003.12.009, 15157953.
38. Liebmann PM, Reibnegger G, Lehofer M, Moser M, Purstner P, Mangge H, Schauenstein K. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-r75) receptor in humans - a possible explanation for the circadian kinetics of TNR-a effects. Inter Immunol 1998, 10(9):1393-6.
39. Portney LG, Watkins MP. Foundations of clinical research: applications to practice 2000, New Jersey: Prentice Hall, Inc, 2.
40. Pereira LSM, Silva FMP, Oliveira DGM, Coelho FM, Souza DG, Dias RC. Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women. Archiv Gerontol and Ger 2009, 48:313-16.